Mental health professionals' views and experiences of antipsychotic reduction and discontinuation | PLOS ONE
![Coming off antipsychotics may take years: first paper on how to withdraw | UCL News - UCL – University College London Coming off antipsychotics may take years: first paper on how to withdraw | UCL News - UCL – University College London](https://www.ucl.ac.uk/news/sites/news/files/pills_3.jpg)
Coming off antipsychotics may take years: first paper on how to withdraw | UCL News - UCL – University College London
![Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies - The Lancet Psychiatry Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies - The Lancet Psychiatry](https://www.thelancet.com/cms/attachment/064281c8-6e6b-438b-91fd-1139e1d974f4/gr1.gif)
Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies - The Lancet Psychiatry
![Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study - The Lancet Psychiatry Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study - The Lancet Psychiatry](https://www.thelancet.com/cms/asset/00a9f86a-4183-4389-af48-164b1e702882/gr1.gif)
Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study - The Lancet Psychiatry
![Antipsychotic Withdrawal Syndrome - Understanding the Hyperbolic Curve and Tapering Antipsychotic Treatment to Reduce the Risk of Relapse Antipsychotic Withdrawal Syndrome - Understanding the Hyperbolic Curve and Tapering Antipsychotic Treatment to Reduce the Risk of Relapse](https://psychscenehub.com/wp-content/uploads/2021/10/Symptoms-of-Antipsychotic-Withdrawal-Syndrome.png)
Antipsychotic Withdrawal Syndrome - Understanding the Hyperbolic Curve and Tapering Antipsychotic Treatment to Reduce the Risk of Relapse
![Beyond antipsychotics: a twenty-first century update for preclinical development of schizophrenia therapeutics | Translational Psychiatry Beyond antipsychotics: a twenty-first century update for preclinical development of schizophrenia therapeutics | Translational Psychiatry](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41398-022-01904-2/MediaObjects/41398_2022_1904_Fig1_HTML.png)
Beyond antipsychotics: a twenty-first century update for preclinical development of schizophrenia therapeutics | Translational Psychiatry
![When Should Antipsychotics for the Management of Behavioral and Psychological Symptoms of Dementia be Discontinued? When Should Antipsychotics for the Management of Behavioral and Psychological Symptoms of Dementia be Discontinued?](https://s3.amazonaws.com/HMP/hmp_ln/imported/inline-images/Screen%20Shot%202019-06-06%20at%2010.18.36%20AM.png)
When Should Antipsychotics for the Management of Behavioral and Psychological Symptoms of Dementia be Discontinued?
![Frontiers | The More, the Merrier…? Antipsychotic Polypharmacy Treatment Strategies in Schizophrenia From a Pharmacology Perspective Frontiers | The More, the Merrier…? Antipsychotic Polypharmacy Treatment Strategies in Schizophrenia From a Pharmacology Perspective](https://www.frontiersin.org/files/Articles/760181/fpsyt-12-760181-HTML/image_m/fpsyt-12-760181-g001.jpg)
Frontiers | The More, the Merrier…? Antipsychotic Polypharmacy Treatment Strategies in Schizophrenia From a Pharmacology Perspective
![To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial | Trials | Full Text To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial | Trials | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13063-019-3822-5/MediaObjects/13063_2019_3822_Fig1_HTML.png)
To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial | Trials | Full Text
![Long-acting injectable antipsychotics: a useful and well tolerated option in elderly patients with psychotic illnesses | SpringerLink Long-acting injectable antipsychotics: a useful and well tolerated option in elderly patients with psychotic illnesses | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.2165%2F00042310-200420120-00003/MediaObjects/40267_2012_20120007_Tab1.jpg)